Compare ACHV & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | GAIN |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 651.5M |
| IPO Year | 2018 | 2005 |
| Metric | ACHV | GAIN |
|---|---|---|
| Price | $8.18 | $15.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $14.67 | ★ $14.75 |
| AVG Volume (30 Days) | ★ 1.4M | 149.8K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 9.19% |
| EPS Growth | N/A | ★ 20.63 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.07 |
| Revenue Next Year | N/A | $7.32 |
| P/E Ratio | ★ N/A | $20.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $13.14 |
| 52 Week High | $8.64 | $17.14 |
| Indicator | ACHV | GAIN |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 37.54 |
| Support Level | $4.03 | $15.78 |
| Resistance Level | $8.63 | $16.94 |
| Average True Range (ATR) | 0.37 | 0.26 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 75.46 | 11.90 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S., to achieve and grow current income by investing in debt securities of established businesses, and to provide stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.